To India will test the first domestic MRNK-vaccine

It is expected that in February tests of the first in India a matrix MRNK-vaccine will begin. About it reports ANI, the partner of the TV network of BRICS. Company Gennova Biopharmaceuticals located in Poona, submitted data on a phase of 2 vaccines of MRNK, and also finished data collection on a phase 3. It is expected that soon Committee of subject examinations (SEC) of the General controler of medicines India (DCGI) will consider these data, reported official sources. Gennova Biopharmaceuticals also developed a MRNK-vaccine for Omicron option which soon will be tested in public on efficiency...